Mangogen Pharma
About Mangogen Pharma
Mangogen Pharma is a bio-engineering company with a mission to develop gene-delivering medical devices that improve human health. Mangogen owns technology that utilizes encapsulated genetically modified baculoviruses coated on to medical devices. On device deployment, the virus enters the local cells, delivers the human gene, and an active protein is expressed.
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Mangogen Pharma Patents
Mangogen Pharma has filed 2 patents.
The 3 most popular patent topics include:
- Clusters of differentiation
- Implants (medicine)
- Molecular biology
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
8/20/2018 | 8/9/2022 | Transcription factors, Molecular biology, Clusters of differentiation, Implants (medicine), Vascular diseases | Grant |
Application Date | 8/20/2018 |
|---|---|
Grant Date | 8/9/2022 |
Title | |
Related Topics | Transcription factors, Molecular biology, Clusters of differentiation, Implants (medicine), Vascular diseases |
Status | Grant |
Mangogen Pharma Frequently Asked Questions (FAQ)
Where is Mangogen Pharma's headquarters?
Mangogen Pharma's headquarters is located at 500 Cartier West Blvd., Laval.
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.
